News for KAYS Stock

Kaya Holdings, Inc. (OTCQB:KAYS): The Sacred Mushroom, Oregon's Premier Psilocybin Treatment Center Introduces "Synergy by Design" Journey Customization Program Kaya Holdings, Inc. and the Sacred Mushroom(TM) Psilocybin Treatment Facility Announce Inaugural Open House and New Series of Low-Dose Psilocybin Sessions The Sacred Mushroom(TM) Psilocybin Center Operated by Kaya Holdings, Inc. (OTCQB:KAYS) Releases First E-Book Kaya Holdings, Inc. (OTCQB:KAYS) Criticizes FDA Rejection of MDMA Therapy for PTSD, Proposes Psilocybin as Alternative Treatment Kaya Holdings, Inc. Announces Grand Opening of The Sacred Mushroom, Oregon's Premier Psilocybin Center Kaya Holdings, Inc. "The Sacred Mushroom" Psilocybin Treatment Center Begins Accepting Appointments Kaya Holdings Awarded Psilocybin Service Center License, Launches The Sacred Mushroom Psychedelic Treatment Facility Kaya Holdings (OTCQB:KAYS) Unveils "The Scared Mushroom(TM)", the First U.S.-Based Psilocybin Center to be Operated by a U.S. Public Company Pioneers and Innovators in Psilocybin Treatments and How Big Pharma Wants in on the Game Kaya Holdings (OTCQB:KAYS) Closes Additional Round of Non-Dilutive Bridge Financing Targeted to Complete The Sacred Mushroom(TM) Psilocybin Treatment Center Kaya Holdings (OTCQB:KAYS) Secures Site for The Sacred Mushroom(TM) Planned Psilocybin Treatment Center Kaya Holdings, Inc.’s V.P. Bryan Arnold Among First Ten (10) State Licensed Psilocybin Facilitators in U.S.A. Kaya Holdings, Inc. Psychedelics Subsidiary Taps Total Holistic Center to Develop Ketamine Treatment Model for Launch of Fifth Dimension Therapeutics Mind Care Clinics Kaya Holdings, Inc. (OTCQB:KAYS) Launches Fifth Dimension Therapeutics(TM) to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and address the Growing Multi-Billion Dollar Global Psychedelics Market Kaya Holdings to Seek Licenses for First Ever State Legal Psilocybin Manufacturing and Facilitation Service Centers in Oregon Cannabis Company Kaya Holdings, Inc's Greek Joint Venture Receives Crucial Installation License for 50K Sq. Ft. Medical Cannabis Facility in Epidaurus, Greece Cannabis Company Kaya Holdings, Inc Acquires 50% of 2nd Medical Cannabis Project in Epidaurus, Greece Kaya Holdings, Inc. Completes Sale of Cannabis Facility for $1.325 MM, Generating Cash Influx of Approximately $0.09 per share for KAYS Operations and International Expansion Cannabis Company Kaya Holdings, Inc. Sunstone Settlement Effective: Share Return Reduces Stock Float by 6.4%, Release of Lien Allows KAYS to Sell Warehouse Property for Cash Influx of up to $0.10 per Share OTCQB:KAYS Duane Morris Co-Sponsored Webinar on Cannabis in Greece Featuring Kaya Holdings Along With Other Industry Experts Starts Shortly Cannabis Company Kaya Holdings, Inc's Management to be Featured Speakers for Duane Morris Co-sponsored Webinar on Cannabis in Greece Cannabis Company Kaya Holdings’ Israeli Subsidiary Receives Initial Approval for Cannabis Cultivation and Processing License International Cannabis Company Kaya Holdings Launches $4 Million Rule 506(c) Offering Kaya Holdings Greek and Israeli Medical Cannabis Projects Zoom Update Today at 2:00 PM EST Greek and Israeli Medical Cannabis Projects Zoom Update to be Held September 2, 2020 International Cannabis Company Kaya Holdings' Greek CBD Pet Products Partnership Hires Prominent Industry Veteran as CEO International Cannabis Company Kaya Holdings Receives Buy Rating, Fair Value Estimate of $0.89 in Fundamental Research Corp Profile Kaya Holdings, Inc.'s (OTCQB:KAYS) Cannabis Retailer Kaya Shack(TM) Launches "Pot 4 a Shot" Vaccination Appreciation Program